[Therapeutic Options in Juvenile Idiopathic Arthritis : Part 1: Nonsurgical Treatment]

Overview

Journal Orthopade

Specialty Orthopedics

Date 2018 Oct 7

PMID 30291372

Citations 2

Authors

J-P Haas

M Arbogast

Affiliations

Soon will be listed here.

Abstract

The treatment of children and adolescents with juvenile idiopathic arthritis (JIA) has progressed substantially during recent years. Multiple different factors have played a role in this advancement: improved medical treatment due to the introduction of new drugs, structural improvements with provision of units specializing in childhood rheumatology, multidisciplinary treatment concepts, structured educational programs for patients and parents, improved functional treatment including sports therapy, and selective surgical and orthopedic interventions improving functional capacities. Current treatment strategies in JIA are aimed at achieving disease remission, i.e., control of disease activity and re-establishment of age-appropriate functional capacities. This review summarizes important developments in the conservative treatment of JIA. Part 2 deals with orthopedic and surgical treatment strategies.

Citing Articles

[Rheumatic pain and chronic pain in children, adolescents and young adults].

Hofel L, Draheim N, Schramm A, Georgi M, Haas J Z Rheumatol. 2021; 80(3):234-242.

PMID: 33416985 DOI: 10.1007/s00393-020-00956-3.

[Clinical characteristics and biological treatment of adult patient with juvenile idiopathic arthritis].

Wei S, Li S, Liu Y Beijing Da Xue Xue Bao Yi Xue Ban. 2020; 52(6):1014-1022.

PMID: 33331307 PMC: 7745272.

References

Hugle B, Haas J, Benseler S . Treatment preferences in juvenile idiopathic arthritis - a comparative analysis in two health care systems. Pediatr Rheumatol Online J. 2013; 11(1):3. PMC: 3573942. DOI: 10.1186/1546-0096-11-3. View

Krumrey-Langkammerer M, Hafner R . Evaluation of the ILAR criteria for juvenile idiopathic arthritis. J Rheumatol. 2001; 28(11):2544-7. View

Barlow J, Ellard D . The psychosocial well-being of children with chronic disease, their parents and siblings: an overview of the research evidence base. Child Care Health Dev. 2006; 32(1):19-31. DOI: 10.1111/j.1365-2214.2006.00591.x. View

Church L, McDermott M . Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders. Curr Opin Mol Ther. 2009; 11(1):81-9. View

Dueckers G, Guellac N, Arbogast M, Dannecker G, Foeldvari I, Frosch M . Evidence and consensus based GKJR guidelines for the treatment of juvenile idiopathic arthritis. Clin Immunol. 2011; 142(2):176-93. DOI: 10.1016/j.clim.2011.10.003. View

Ammerlaan J, Scholtus L, Bijlsma H, Prakken B, Kruize A . An urge for change: transitional care for young adults with juvenile idiopathic arthritis. Patient Educ Couns. 2013; 92(1):127-9. DOI: 10.1016/j.pec.2013.02.006. View

Petty R, Southwood T, Baum J, Bhettay E, Glass D, Manners P . Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol. 1998; 25(10):1991-4. View

Truckenbrodt H, Hafner R . Methotrexate therapy in juvenile rheumatoid arthritis: a retrospective study. Arthritis Rheum. 1986; 29(6):801-7. DOI: 10.1002/art.1780290616. View

Boom V, Anton J, Lahdenne P, Quartier P, Ravelli A, Wulffraat N . Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2015; 13:55. PMC: 4669611. DOI: 10.1186/s12969-015-0055-3. View

10.

Dueckers G, Guellac N, Arbogast M, Dannecker G, Foeldvari I, Frosch M . [Evidence and consensus based treatment guidelines 2010 for juvenile idiopathic arthritis by the German Society of Paediatric Rheumatology]. Klin Padiatr. 2011; 223(6):386-94. DOI: 10.1055/s-0031-1287837. View

11.

Hartmann M, Kreuzpointner F, Haefner R, Michels H, Schwirtz A, Haas J . Effects of juvenile idiopathic arthritis on kinematics and kinetics of the lower extremities call for consequences in physical activities recommendations. Int J Pediatr. 2010; 2010. PMC: 2939399. DOI: 10.1155/2010/835984. View

12.

Sengler C, Klotsche J, Niewerth M, Liedmann I, Foll D, Heiligenhaus A . The majority of newly diagnosed patients with juvenile idiopathic arthritis reach an inactive disease state within the first year of specialised care: data from a German inception cohort. RMD Open. 2015; 1(1):e000074. PMC: 4680591. DOI: 10.1136/rmdopen-2015-000074. View

13.

Beukelman T . Treatment advances in systemic juvenile idiopathic arthritis. F1000Prime Rep. 2014; 6:21. PMC: 3974570. DOI: 10.12703/P6-21. View

14.

Takken T, Van Brussel M, Engelbert R, Van Der Net J, Kuis W, Helders P . Exercise therapy in juvenile idiopathic arthritis. Cochrane Database Syst Rev. 2008; (2):CD005954. PMC: 8903819. DOI: 10.1002/14651858.CD005954.pub2. View

15.

Andrews N, Chaney J, Mullins L, Wagner J, Hommel K, Jarvis J . The differential effect of child age on the illness intrusiveness--parent distress relationship in juvenile rheumatic disease. Rehabil Psychol. 2009; 54(1):45-50. DOI: 10.1037/a0014443. View

16.

Hinze C, Holzinger D, Lainka E, Haas J, Speth F, Kallinich T . Practice and consensus-based strategies in diagnosing and managing systemic juvenile idiopathic arthritis in Germany. Pediatr Rheumatol Online J. 2018; 16(1):7. PMC: 5778670. DOI: 10.1186/s12969-018-0224-2. View

17.

Tarakci E, Yeldan I, Baydogan S, Olgar S, Kasapcopur O . Efficacy of a land-based home exercise programme for patients with juvenile idiopathic arthritis: a randomized, controlled, single-blind study. J Rehabil Med. 2012; 44(11):962-7. DOI: 10.2340/16501977-1051. View

18.

Horneff G, Klein A, Ganser G, Sailer-Hock M, Gunther A, Foeldvari I . Protocols on classification, monitoring and therapy in children's rheumatology (PRO-KIND): results of the working group Polyarticular juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2017; 15(1):78. PMC: 5678777. DOI: 10.1186/s12969-017-0206-9. View

19.

Allantaz F, Chaussabel D, Stichweh D, Bennett L, Allman W, Mejias A . Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. J Exp Med. 2007; 204(9):2131-44. PMC: 2118700. DOI: 10.1084/jem.20070070. View

20.

Michels H, Ganser G, Dannecker G, Forster J, Hafner R, Horneff G . [Structural quality of rheumatology clinics for children and adolescents. Paper by a task force of the "Society of Pediatric and Adolescent Rheumatology" and of the "Association of Rheumatology Clinics in Germany"]. Z Rheumatol. 2006; 65(4):315-22, 324-6. DOI: 10.1007/s00393-006-0056-1. View